Skip to main content

Inovio Pharmaceuticals, Inc.

INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001055726

No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of INO: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders10399−4
Shares10.2M20.7M+10.5M (+103.7%)
Value$20.7M$48.4M+$27.8M (+134.1%)

New holders (24)

Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to INO in Q3 2025
InstitutionSharesValue% of portfolio
Adage Capital Partners GP, L.L.C.3,428,571$8.02M0.01%
Janus Henderson Group PLC3,266,260$7.63M0.00%
Boxer Capital Management, LLC2,300,000$5.38M1.72%
D. E. Shaw & Co., Inc.806,742$1.89M0.00%
Two Sigma Advisers, LP108,701$254.4K0.00%
Quadrature Capital Ltd37,115$86.8K0.00%
Greenwich Wealth Management LLC20,399$48.0K0.00%
Zacks Investment Management19,455$45.5K0.00%
Jacobs Levy Equity Management, Inc17,673$41.4K0.00%
Colony Group, LLC14,289$33.4K0.00%
Stephens Inc13,500$31.6K0.00%
SG Americas Securities, LLC11,497$27.0K0.00%
MCF Advisors LLC11,274$26.4K0.00%
Meridian Wealth Management, LLC10,000$23.4K0.00%
Rockefeller Capital Management L.P.2,037$4.77K0.00%
Legacy Wealth Managment, LLC1,356$3.17K0.00%
Root Financial Partners, LLC208$4870.00%
SRS Capital Advisors, Inc.103$2410.00%
Ameritas Investment Partners, Inc.64$1500.00%
Optiver Holding B.V.24$560.00%
Groupe la Francaise20$420.00%
Wealthspire Advisors, LLC15$360.00%
Harbour Investments, Inc.3$70.00%
Atlantic Union Bankshares Corp1$20.00%

Sold out (28)

Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.